All Posts

EXPERT COMMENTARY – ASCO26

Perspectives synthesized from ASCO 2026 presenter and discussant sessions and post-meeting expert commentary. Prepared for educational purposes by the Kidney Cancer Journal editorial team. Toni K. Choueiri, MD, FASCO. Dana-Farber Cancer Institute, Boston, MA. Presenter — LITESPARK-022 and KEYNOTE-564 ctDNA Analysis…

Latest Updates by KidNEYCAnCeR June 17, 2026

85Views 0Comments

Management of Carcinoid Tumor within a Horseshoe Kidney

Andrea Lopez Sanmiguel1, Dilara Akbulut1, Jeff Chen1, Yash S. Khandwala1, Paul Russo1† Affiliations: 1 Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY Abstract Horseshoe kidney is the most common renal fusion…

Articles by KidNEYCAnCeR June 17, 2026

350Views 0Comments

ASCO 2026 Annual Meeting: Kidney Cancer: Clinical and Research Highlights

doi.org/10.52733/ASCO26Summary Thomas E. Hutson, DO, PharmD, FACP Editor-in-Chief, Kidney Cancer Journal A Summary Report for the Global Oncology Community Chicago, Illinois | May 29 – June 2, 2026 | Kidney Cancer Journal, Volume 24…

2026 ASCO Latest Updates by KidNEYCAnCeR June 17, 2026

207Views 0Comments

The Architecture of a Cure: Where Renal Cell Carcinoma Research Stands in 2026

Thomas E. Hutson, DO, PharmD, FACP EDITORIAL NOTE | Editor-in-Chief, Kidney Cancer Journal There is a particular kind of optimism that belongs only to a field in the midst of genuine transformation…

Articles Latest Updates by KidNEYCAnCeR June 15, 2026

339Views 0Comments

Most Clinically Significant Kidney Cancer Presentations from ASCO 2026

Selected by the Editor-in-Chief | Kidney Cancer Journal, Volume 24(2) Primary data drawn from ASCO 2026 presentations, JCO supplement abstracts, press releases, and peer-reviewed commentary. Abstract 1 — LBA418 LITESPARK-022: Pembrolizumab Plus Belzutifan Versus Pembrolizumab Plus Placebo as Adjuvant Therapy for Clear…

145Views 0Comments

Journal Club

Significant Recent Publications in Kidney Cancer Curated by the Editorial Team, Kidney Cancer Journal | Volume 24(2) Includes clinical trials and randomized controlled trials published within the past 10 weeks in high-impact peer-reviewed journals. █ CheckMate 9ER Final Analysis:…

Articles Latest Issue new blog by KidNEYCAnCeR May 25, 2026

700Views 0Comments

Renal Cell Carcinoma at the ASCO 2026 Inflection Point -Pre-meeting Preview

May 29–June 2, 2026 | Chicago, IL Senthil Pazhanisamy, BPharma, MS, PhD. Overview The 2026 ASCO Annual Meeting arrives at a critical inflection point for renal cell carcinoma (RCC). The February ASCO GU Symposium in San Francisco delivered a rapid sequence of…

Articles by KidNEYCAnCeR May 21, 2026

149Views 0Comments

Modifiable risk factors for kidney cancer among adults in India: A systematic review to recommend the most effective preventive measures for kidney cancer in India.

Nitinkumar Moradiya University Of Sunderland, Harbour Exchange Square, E14 9GE, London, United Kingdom. ABSTRACT Background: Kidney cancer is an emerging public health concern in India, with rising incidence rates and a significant economic burden. While global research has identified common risk…

Journal Club Trending by KidNEYCAnCeR April 24, 2026

1376Views 0Comments

Featured Journal Club Articles

█ EAU guidelines on renal cell carcinoma: the 2025 update Citation: Bex A, Abu Ghanem Y, Albiges L, et al. Eur Urol. 2025;87(6):683–696. doi:10.1016/j.eururo.2025.02.020. PMID: 40118739. Background: The EAU RCC guideline panel conducts annual structured updates of its evidence-based recommendations for the…

GU26 ASCO by KidNEYCAnCeR April 22, 2026

2192Views 0Comments

Seleted Presentations from GU ASCO 2026 in Renal Cancer.

This document presents full abstract summaries for the ten kidney cancer abstracts selected by the Editor-in-Chief as the most clinically significant presentations from GU ASCO 2026. Each entry includes background, methods, key results, safety profile, and editorial perspective. Abstracts are ordered by…

All Posts

EXPERT COMMENTARY – ASCO26

Management of Carcinoid Tumor within a Horseshoe Kidney

ASCO 2026 Annual Meeting: Kidney Cancer: Clinical and Research Highlights

The Architecture of a Cure: Where Renal Cell Carcinoma Research Stands in 2026

Most Clinically Significant Kidney Cancer Presentations from ASCO 2026

Journal Club

Renal Cell Carcinoma at the ASCO 2026 Inflection Point -Pre-meeting Preview

Modifiable risk factors for kidney cancer among adults in India: A systematic review to recommend the most effective preventive measures for kidney cancer in India.

Seleted Presentations from GU ASCO 2026 in Renal Cancer.

About Us

Contents

Follow Us

Guidelines

Patient Resources